Company intelligence
Gilead Sciences
About Gilead Sciences
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines
Verified activity
Signals from Gilead Sciences
17 published signals
People
Gilead Sciences co-chairs Justine Rochon and Janice Branson joined Patrick Loerch as co-chair of the DISRUPT-DS (Data Science) Roundtable.
Reported by Patrick Loerch
Presence & Recognition
Gilead Sciences is coordinating the Upstream Processing area for the ACS BIOT Spring 2027 conference in New Orleans, Louisiana, with abstract submission deadline September 28, 2026.
Reported by Huong Le
Presence & Recognition
Gilead Sciences is hosting the 2026 CABS BioPacific Conference on September 19 at the South San Francisco Conference Center with keynote speakers and panels.
Reported by Liping Meng
Presence & Recognition
Gilead Sciences attended SAP Connect Day for Life Sciences in Palo Alto, CA.
Reported by Baris Celik
Presence & Recognition
Gilead Sciences presented the FDA Post-Marketing Pregnancy Study Requirements: Evaluating Study Reporting and Label Integration work during the Delivering Meaningful Answers in Clinical Decision-Making for Prenatal Exposures session at ISPE 42nd Annual Meeting in Milan.
Reported by Jami Peters
Presence & Recognition
Gilead Sciences featured Dr. Carlo Tornatore sharing an open letter about his experience with cancer, CAR-T therapy, and how it made him a more compassionate doctor.
Reported by Gilead Sciences
People
Gilead Sciences is seeking a Senior Director, HCP Promotions, US HIV Treatment Marketing to drive healthcare provider engagement strategies for a leading HIV treatment brand.
Reported by Tim Flynn
Presence & Recognition
Gilead Sciences is attending the 2026 BIOPACIFIC Conference on September 19, featuring keynote speakers including Flavius Martin, Randy Schekman, Joseph C. Wu, Jan Smith, Keting Chu, and Yuling Luo.
Reported by Jessica Yuan
Presence & Recognition
Gilead Sciences featured Jared in an episode of Things Everyone Should Know About Gilead discussing innovation paired with impact in the fight against HIV.
Reported by Gilead Sciences
Presence & Recognition
Gilead Sciences is hosting an online event on September 17th at 11am EDT featuring a discussion on connected drug delivery devices hosted by Drug Delivery Leader.
Reported by Monica Swinney, Ph.D.
Presence & Recognition
Gilead Sciences is presenting a poster entitled Crystallization Process Development to Increase Primary Particle Growth for a Low Soluble Mono-Citrate Salt, Edecesertib at AAPS (PharmSci 360) in New Orleans, LA on Wednesday, October 28th at 10:30AM in Forum 7 on Monitor 41.
Reported by Henry Morrison
Research & Knowledge
Gilead Sciences contributed to a publication discussing PFAS and its role in pharmaceutical manufacturing.
Reported by Jonathan Tripp
People
Gilead Sciences is hiring for a Senior Scientist in AI and Biologics Design.
Reported by Saeed Izadi
People
Gilead Sciences welcomed Andrea Zanaglio over the past four years.
Reported by Andrea Zanaglio
Research & Knowledge
Gilead Sciences published the stories of Janet and Vanessa, two women living with metastatic triple-negative breast cancer who started treatment on an antibody-drug conjugate (ADC).
Reported by Gilead Sciences
Research & Knowledge
Gilead Sciences supported Janet and Vanessa, two women living with metastatic triple-negative breast cancer, sharing their experiences with an antibody-drug conjugate or ADC.
Reported by Darren Tayama, MD
Presence & Recognition
Gilead Sciences participated in the 2026 Asia-Pacific Economic Cooperation (APEC) HIV Policy Dialogue in China, focusing on advancing implementation of the APEC Action Plan to End the HIV Epidemic and accelerating progress toward the 2030 HIV goals.
Reported by Gilead Sciences